Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1442 of includes/bootstrap.inc).

G 0002/04 (Transfer of opposition/HOFFMANN-LA ROCHE) of 25.5.2005

European Case Law Identifier:

ECLI:EP:BA:2005:G000204.20050525

Date of decision:

25 May 2005

Case number:

G 0002/04

Referral:

Application number:

IPC class:

Language of proceedings:

EN

Distribution:

A

Download and more information:

Decision text in EN (PDF, 114Â KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	OJ \| Published

Title of application:

Methods for detection of carcinoma metastases by nucleic acid amplification

Applicant name:

F. HOFFMANN-LA ROCHE AG, et al.

Opponent name:

(1) Akzo Nobel N.V.
(2) Vysis Inc.

Board:

EBA

Headnote:

(see Order)

Relevant legal provisions:

European Patent Convention 1973 Art 58
European Patent Convention 1973 Art 99(1)
European Patent Convention 1973 Art 105
European Patent Convention 1973 Art 107
European Patent Convention 1973 Art 108
European Patent Convention 1973 Art 112(1)(a)
European Patent Convention 1973 Art 114(2)
European Patent Convention 1973 Art 134
European Patent Convention 1973 R 20
European Patent Convention 1973 R 60(2)
European Patent Convention 1973 R 61
European Patent Convention 1973 R 64(a)
European Patent Convention 1973 R 65(2)
European Patent Convention 1973 R 88
European Patent Convention 1973 R 101(1)
European Patent Convention 1973 R 101(4)

Keywords:

Admissibility of the referral (yes)
Transfer of opponent status - free transfer (no) - transfer to subsidiary in whose interest the opposition was filed (no)
Correction of the appellant contrary to true intentions (no)
Auxiliary request concerning the person of the appellant in case of legal uncertainty

Catchwords:

-

Cited decisions:

G 0004/88
G 0009/91
G 0010/91
G 0008/92
G 0009/93
G 0001/97
G 0003/97
G 0003/99
J 0016/94
J 0027/94
T 0563/89
T 0659/92
T 0670/95
T 0298/97
T 0097/98
T 0964/98
T 0711/99
T 0009/00
T 0715/01
T 0854/02

Citing decisions:

G 0001/12
G 0001/13
G 0002/19
J 0037/03
J 0038/03
J 0017/12
T 0147/00
T 0416/00
T 1071/00
T 0136/01
T 0561/01
T 1086/02
T 1091/02
T 0207/03
T 0293/03
T 0345/03
T 0503/03
T 0956/03
T 1178/04
T 0006/05
T 0108/05
T 0659/05
T 0675/05
T 0677/05
T 0724/05
T 1421/05
T 0426/06
T 0875/06
T 1081/06
T 1206/06
T 1324/06
T 0391/07
T 0500/07
T 0993/07
T 1668/07
T 1697/07
T 0384/08
T 0445/08
T 0737/08
T 0960/08
T 1588/08
T 1790/08
T 1877/08
T 1145/09
T 1284/09
T 1938/09
T 1982/09
T 0128/10
T 0284/10
T 0518/10
T 1032/10
T 0184/11
T 0577/11
T 2136/11
T 0545/12
T 0796/12
T 0854/12
T 1138/12
T 2016/12
T 2357/12
T 1729/13
T 0615/14
T 0194/15
T 0219/15
T 0660/15
T 1001/15
T 1068/15
T 1415/16
T 2136/16
T 2707/16
T 0488/18

Source: http://www.epo.org/law-practice/case-law-appeals/recent/g040002ex1.html

Date retrieved: 17 May 2021

87 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

X A.58 EPC Entitlement to file a European patent application

X A.99 EPC Opposition

X A.105 EPC Intervention of the assumed infringer

X A.107 EPC Persons entitled to appeal and to be parties to appeal proceedings

X A.108 EPC Time limit and form

X A.112 EPC Decision or opinion of the Enlarged Board of Appeal

X A.113 EPC Right to be heard and basis of decisions

X A.134 EPC Representation before the European Patent Office

EPC Implementing Rules

X R.89 EPC Intervention of the assumed infringer

X R.101 EPC Rejection of the appeal as inadmissible

EPO Guidelines - D Opposition and Limitation/Revocation Procedures

X GL D I 4 Entitlement to oppose

Offical Journal of the EPO

X OJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)

X OJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)

X OJ EPO 2020, A87 - Decision of the Enlarged Board of Appeal of 16 July 2019 - G 2/19

X OJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)

X OJ EPO 2015, A42 - Decision of the Enlarged Board of Appeal dated 25 November 2014 - G 1/13

X OJ EPO 2014, A114 - Decision of the Enlarged Board of Appeal dated 30 April 2014 - G 1/12

Case Law Book: III Amendments

X CLR III O 1 Party status as patent proprietor

X CLR III O 2.1 General principles

X CLR III O 2.4 No transfer: sale of opponent's subsidiary company

X CLR III O 2.5 Legal uncertainty as to who is the correct party

Case Law Book: V Priority

X CLR V B 2.3.3 Relevance of the referred question for the underlying case

X CLR V B 2.3.5 Pending proceedings

Case Law of the Enlarged Board

X G 0004/88 (Transfer of opposition) of 24.4.1989

X G 0009/91 (Power to examine) of 31.3.1993

X G 0010/91 (Examination of opposition/appeals) of 31.3.1993

X G 0008/92 (Vorlage an die GroÃe Beschwerdekammer/KLEHR) of 5.3.1993

X G 0009/93 (Opposition by patent proprietor) of 6.7.1994

X G 0001/97 (Request with a view to revision) of 10.12.1999

X G 0003/97 (Opposition on behalf of a third party) of 21.1.1999

X G 0003/99 (Admissibility of joint opposition or joint appeal/HOWARD FLOREY) of 18.2.2002

X G 0001/12 () of 30.4.2014

X G 0001/13 (Fischer-Tropsch Catalysts/SASOL TECHNOLOGY II) of 25.11.2014

X G 0002/19 (Rechtliches GehÃ¶r und richtiger Verhandlungsort) of 16.7.2019

General Case Law

X J 0016/94 (Notice of appeal) of 10.6.1996

X J 0027/94 (Divisional application) of 27.2.1995

X J 0037/03 (Withdrawal of application/3M I) of 15.3.2006

X J 0038/03 (Withdrawal of application/3M II) of 15.3.2006

X J 0017/12 () of 13.11.2013

X T 0563/89 () of 3.9.1991

X T 0659/92 (Transfer of opposition) of 24.10.1994

X T 0670/95 (Zementzusammensetzung/SIKA) of 9.6.1998

X T 0298/97 (Detergent compositions/UNILEVER) of 28.5.2001

X T 0097/98 (Spinning process/MINNTECH) of 21.5.2001

X T 0711/99 (Transfer of opposition/L'OREAL) of 21.10.2003

X T 0009/00 (Opposition/HENKEL) of 18.12.2001

X T 0416/00 () of 24.1.2006

X T 0136/01 () of 30.11.2005

X T 0715/01 (Glycosides/COGNIS) of 24.9.2002

X T 0854/02 (Use of taxol/BRISTOL-MYERS SQUIBB) of 14.10.2002

X T 1091/02 (Methods for detection/HOFFMANN-LA ROCHE) of 23.7.2004

X T 0207/03 () of 8.3.2007

X T 0956/03 (NMR/ABBOTT LABORATORIES) of 19.7.2006

X T 1178/04 (Enzyme additives for ruminant feeds/HER MAJESTY THE QUEEN IN RIGHT OF … of 27.2.2007

X T 0006/05 (Method for transferring heat/SOLVAY SOLEXIS) of 9.10.2007

X T 1421/05 () of 18.1.2011

X T 0875/06 () of 12.3.2008

X T 1081/06 () of 10.10.2008

X T 1324/06 () of 14.7.2008

X T 0993/07 (Field device management system/FISCHER-ROSEMOUNT) of 20.5.2010

X T 1668/07 () of 27.10.2011

X T 0384/08 (Method for investigating/AFFYMETRIX) of 26.6.2009

X T 0445/08 (Water Filtration/Zenon/Identity of the Appellant) of 26.3.2015

X T 0960/08 (Transfer of opposition/VDO Automotive AG) of 1.12.2011

X T 1790/08 (SchlieÃelement/METZELER) of 29.7.2009

X T 1877/08 (Refrigerants/E.I. DU PONT DE NEMOURS AND COMPANY) of 23.2.2010

X T 1284/09 () of 1.9.2010

X T 1938/09 (Objection for suspicion of partiality) of 2.10.2014

X T 1982/09 (Communication method/SONY) of 27.4.2012

X T 0128/10 () of 10.12.2010

X T 0518/10 (Lucenin-2 in krill oil extracts/NEPTUNE) of 9.4.2013

X T 1032/10 () of 17.1.2013

X T 0184/11 () of 14.5.2013

X T 0577/11 (Entitlement to priority) of 14.4.2016

X T 0796/12 () of 26.10.2017

X T 0854/12 (Unterbrechung des Verfahrens) of 8.8.2016

X T 1138/12 () of 9.5.2017

X T 2016/12 () of 6.10.2017

X T 2357/12 (Universal succession) of 28.11.2013

X T 0615/14 () of 27.10.2015

X T 0194/15 (Anti-TNF antibodies and methotrexate/THE KENNEDY TRUST) of 9.3.2016

X T 0219/15 () of 2.8.2017

X T 1001/15 (Triggering migration to a network access agent/ALCATEL-LUCENT) of 2.8.2018

X T 1068/15 (Migration of a network access agent/ALCATEL-LUCENT) of 2.8.2018

X T 1415/16 (PCV-2 Vaccine/INTERVET) of 23.5.2017

X T 2136/16 () of 11.9.2017

X T 2707/16 (Dynamically generating multiple hierarchies/MICROSOFT TECHNOLOGY … of 11.12.2018